Clinical Trials Logo

Rectal Neoplasms clinical trials

View clinical trials related to Rectal Neoplasms.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 13

NCT ID: NCT02673177 Not yet recruiting - Rectal Neoplasms Clinical Trials

Trial of Robotic Versus Laparoscopic-assisted Radical Resection for Rectal Cancer

TRVL
Start date: February 2016
Phase: N/A
Study type: Interventional

This study compared robot-assisted total mesorectal excision (RTME) and laparoscopic total mesorectal excision (LTME) with regard to urinary function, sexual function and sphincter- preservation outcomes for low rectal cancer.

NCT ID: NCT02630056 Not yet recruiting - Rectal Neoplasm Clinical Trials

Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer

Start date: December 2015
Phase: N/A
Study type: Observational

The purpose of this study is to validate the dosimetric parameters that correlate with acute hematologic toxicity (HT) in patients with rectal cancer treated with neoadjuvant chemoradiotherapy.

NCT ID: NCT02498353 Not yet recruiting - Rectal Cancer Clinical Trials

Comparing Preoperative Short-course Radiotherapy With or Without Local Boost for Rectal Cancer

Start date: July 2015
Phase: N/A
Study type: Interventional

A randomized trial comparing weather preoperative short-course radiotherapy with local boost is better than conventional preoperative short-course radiotherapy for local advanced rectal cancer.

NCT ID: NCT02439086 Not yet recruiting - Rectal Neoplasms Clinical Trials

Prediction of Response to Neoadjuvant Therapy in Rectal Cancer

PRENT-LARC
Start date: September 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether 18F-FDG-PET-CT and texture analysis of MRI performed 9 weeks after Neoadjuvant Chemo-radiotherapy in patients with locally advanced rectal cancer has the ability to identify patients with Complete Response.

NCT ID: NCT01142713 Not yet recruiting - Rectal Cancer Clinical Trials

The Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II Study

Start date: August 2010
Phase: Phase 2
Study type: Interventional

Radiotherapy has a significant impact on local control, disease free survival and overall survival in patients with rectal cancer T2, N1, M0 and T3-4, any N, M0. Treatment is accompanied by side effects, mainly due to the inclusion of the small bowel and urinary bladder in the treatment fields. Two major modalities have been pursued to reduce the volume of small intestine and urinary bladder in treatment volume. One is a surgical procedure, such as absorbable mesh. These procedures have failed implementation in daily clinical practice. The second modality aims to save the small intestine and urinary bladder from the toxicity of radiotherapy by modulating the radiotherapy planning procedure. Using the belly board and changing the standard position from supine to prone could achieve this aim; in part due to gravitational displacement of the bowel. Several studies have evaluated the impact of positioning and use of belly board in patients receiving pelvis irradiation for rectal cancer. The results are inconclusive, but the prone position with belly board appears promising. This study carefully evaluates the impact of patient's positioning and belly board on dose volume histogram of small bowel and urinary bladder

NCT ID: NCT01006577 Not yet recruiting - Rectal Cancer Clinical Trials

Side-to-end Anastomosis Versus Colon J Pouch for Reconstruction After Low Anterior Resection for Rectal Cancer (SAVE)

SAVE
Start date: June 2010
Phase: N/A
Study type: Interventional

Primary hypothesis: Side-to-end anastomosis is non-inferior to colon J pouch for reconstruction after low anterior resection for rectal cancer in fecal incontinence (Wexner score). Research questions: Are there differences between side-to-end anastomosis and colon J pouch in - bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation) - quality of life - sexual function - urinary function - postoperative complications - operation time/ institutional costs

NCT ID: NCT00964457 Not yet recruiting - Rectum Cancer Clinical Trials

Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients

Start date: August 2009
Phase: Phase 2
Study type: Interventional

response rate to adding cetuximab, oxaliplatin and capecitabine to radiation for advanced rectum cancer

NCT ID: NCT00819559 Not yet recruiting - Rectal Neoplasm Clinical Trials

Preoperative Chemoradiotheray for Rectal Cancer

Start date: March 2009
Phase: N/A
Study type: Interventional

Hypothesis - Pre operative radio-chemotherapy might be not mandatory to improve local recurrent rate and survival rate in the mid-lower rectal cancer patients with T3N0 clinical stage, if surgical principals were kept. - Laparoscopic resection is not inferior to Open surgery in the treatment of rectal cancer.

NCT ID: NCT00199277 Not yet recruiting - Clinical trials for Iron Deficiency Anemia

Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.

Start date: n/a
Phase: Phase 4
Study type: Interventional

The main objective of this study is to evaluate the efficacy of intravenous iron sucrose in increasing preoperative haemoglobin values in patients with colo-rectal neoplasm and iron deficiency anemia, compared to the standard treatment with oral iron. It will also determine whether intravenous iron sucrose administration improves outcomes such as postoperative haemoglobin values, serum ferritin values, transfusional needs, postoperative complications, or length of hospital stay.